Drinking Risk Level Reductions Associated with Improvements in Physical Health and Quality of Life among Individuals with Alcohol Use Disorder

BACKGROUND. Abstinence and no heavy drinking days are currently the only Food and Drug Administration (FDA) approved endpoints in clinical trials for alcohol use disorder (AUD). Many individuals who fail to meet these criteria may substantially reduce their drinking during treatment and most individ...

Full description

Saved in:
Bibliographic Details
Published in:Alcohol Clin Exp Res
Main Authors: Witkiewitz, Katie, Kranzler, Henry R., Hallgren, Kevin A., O’Malley, Stephanie S., Falk, Daniel E., Litten, Raye Z., Hasin, Deborah S., Mann, Karl F., Anton, Raymond F.
Format: Artigo
Language:Inglês
Published: 2018
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6286196/
https://ncbi.nlm.nih.gov/pubmed/30395350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/acer.13897
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items